Novo Nordisk Sogroya Gains Positive CHMP Opinion in Europe
Bagsværd, Denmark, September 18, 2026 Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP)...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Bagsværd, Denmark, September 18, 2026 Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Boston, Massachusetts, U.S., September 18, 2026 ZBeats, a digital health and medical technology company focused on cardiac diagnostics, has...
Chicago, Illinois, USA, Aug 26, 2026 Tempus AI, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance...
BOONE, N.C., July 20, 2026 Fuse Oncology has unveiled FuseRx, an innovative AI-powered prescribing and treatment-intent solution designed to...
SYDNEY, Australia and AUCKLAND, New Zealand, June 21, 2026 Murj®, a leading provider of cardiac device management software, has...
MENLO PARK, Calif., June 10, 2026 Subtle Medical has received U.S. FDA clearance for SubtleHD™(CT), a new artificial intelligence-powered...
